Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Phase I Evidence Stage
Longevity Primary Domain
Subcutaneous injection via auto-injector pen Routes Studied
500+ PubMed Citations
Longevity Peptide
Early-Stage Research

NAD+

Synthetic peptide studied in animal and cell models for cellular energy metabolism support and sirtuin-mediated longevity pathway activation

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
NAD+
Class
Longevity peptide
Summary
Synthetic peptide studied in animal and cell models for cellular energy metabolism support, sirtuin-mediated longevity pathway activation, dna repair capacity enhancement.
Mechanism
Inflammaging & Senescence Modulation
Research Status
Phase I
Routes Studied
Subcutaneous injection via auto-injector pen
Evidence Level
Early-stage research · Clinically unproven
[ QUICK.ANSWERS ]

What Should You Know About NAD+?

What is NAD+?
NAD+ is a synthetic peptide studied in animal and cell models for cellular energy metabolism support and sirtuin-mediated longevity pathway activation.
Is NAD+ clinically proven?
No. Human evidence remains limited and does not establish NAD+ as clinically proven.
What has NAD+ been studied for?
NAD+ has been studied in preclinical models of cellular energy metabolism support, sirtuin-mediated longevity pathway activation, dna repair capacity enhancement. These findings have not been confirmed in large-scale human trials.
Is NAD+ approved?
No. NAD+ is not an approved drug and remains a research compound.
[ COMPOUND.PROFILE ]

What Is NAD+?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, serving as a critical substrate for over 500 enzymatic reactions and functioning as the central electron carrier in cellular energy metabolism. NAD+ exists in two forms: the oxidized form (NAD+) and the reduced form (NADH), and the ratio between these two forms is a fundamental determinant of cellular metabolic state, redox balance, and signaling capacity. The molecule consists...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Early-stage research · Clinically unproven

NAD+ has early-stage clinical data only. Safety data is emerging but efficacy evidence remains limited. Most claims exceed current clinical evidence.

Evidence Breakdown

Domain Evidence Level
Cellular Energy Metabolism Support Limited
Sirtuin-Mediated Longevity Pathway Activation Limited
DNA Repair Capacity Enhancement Limited
Neuroprotective & Cognitive Support Limited
Human clinical evidence Limited
Safety data Insufficient

Editorial Position

NAD+ is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.

Regulatory Status Snapshot

  • Not approved as a therapeutic drug by major regulators
  • Safety profile not established in large human populations

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has NAD+ Been Studied For?

Research areas where NAD+ has been investigated in published studies

  • Cellular Energy Metabolism Support NAD+ has been studied in animal models of cellular energy metabolism support. These findings have not been confirmed in controlled human trials.
  • Sirtuin-Mediated Longevity Pathway Activation NAD+ has been studied in animal models of sirtuin-mediated longevity pathway activation. These findings have not been confirmed in controlled human trials.
  • DNA Repair Capacity Enhancement NAD+ has been studied in animal models of dna repair capacity enhancement. These findings have not been confirmed in controlled human trials.
  • Neuroprotective & Cognitive Support NAD+ has been studied in animal models of neuroprotective & cognitive support. These findings have not been confirmed in controlled human trials.
[ MECHANISM ]

How Does NAD+ Work?

These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.

  1. 01 Direct NAD+ Pool Replenishment
  2. 02 Intracellular signaling
  3. 03 DNA Repair Capacity Restoration
  4. 04 Mitochondrial Electron Transport Optimization
NEXT STEP

Not sure if NAD+ is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about NAD+.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate NAD+

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is NAD+ Administered?

NAD+ is available via Subcutaneous injection via auto-injector pen. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of NAD+?

Format Pre-filled Auto-Injector Pen
Amount 1000mg per pen
Purity >99.0%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Nicotinamide Adenine Dinucleotide (C21H27N7O14P2) - not a peptide; a dinucleotide coenzyme
Molecular Weight 663.43 g/mol
Storage Store refrigerated at 2-8 degrees C. Protect from light. Do not freeze. Use within specified timeframe after first use.
Appearance Clear, colorless to slightly yellow solution in pre-filled pen
[ EXPLORE ]

What Conditions Has NAD+ Been Linked To?

Have Questions About NAD+?

Subcutaneous NAD+ administration commonly produces temporary flushing, warmth, and tingling at the injection site and sometimes more broadly. These effects are typically mild, diminish within 15-30 minutes, and tend to lessen with continued use.

Published studies on NAD+ can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

NAD+ is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.

Ready to discuss NAD+ with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.